Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01097278 · ClinicalTrials.gov registry record · NA
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
A NA study, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- NA
- Development phase
- 208
- Enrollment target
NCT01097278 is a NA study that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 208 participants.
The verdict
NCT01097278, a NA study, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
Study Summary
RATIONALE: Cholecalciferol may prevent breast cancer in premenopausal women. PURPOSE: This randomized phase II trial is studying how well cholecalciferol works in preventing breast cancer in premenopausal women.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2011-11-01 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01097278
The ClinicalTrials.gov registry entry for NCT01097278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01097278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01097278 about?
NCT01097278 is a clinical study titled "S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer". RATIONALE: Cholecalciferol may prevent breast cancer in premenopausal women. PURPOSE: This randomized phase II trial is studying how well cholecalciferol works in preventing breast cancer in premenopausal women.
What is the current status of trial NCT01097278?
This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2011-11-01. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01097278?
The interventions under investigation include: placebo (OTHER), cholecalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01097278?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.